StockMacro
Menu

Rockwell Medical

$5.82 -23% in 6 monthsMarket cap $23.1M

RMTI on XNAS, Health Care, Rockwell Medical, Inc. (DE), job postings

Measures activity, not value. Not investment advice.

Quarterly revenue rose 20% to $19.1M, but shares are down 32% in a year.

  • BadInstitutional holders fell to 27 from 37 in one quarter
  • WatchTwelve-month revenue fell 4.0% to $72.6M

Written by AI from the data on this page, 22 Nov 2026. Not investment advice.

Profile and fundamentals

From its SEC filings, 12 months to 30 Sep 2026

Rockwell Medical Inc is a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products for dialysis providers. It is a supplier of liquid bicarbonate concentrates, acid, and dry bicarbonate concentrates for dialysis patients in the United States. The company's products include CitraPure citric acid concentrate, RenalPure liquid acid concentrate, and SteriLyte bicarbonate concentrate, among others. The company delivers the majority of its hemodialysis concentrates products and mixers to dialysis clinics throughout the United States and internationally, utilizing its own delivery trucks and third-party carriers.

Industry
Pharmaceutical preparations (Health Care)
Employees
157
Website
rockwellmed.com
Listed
Nasdaq, US
Last results
12 Nov 2026
Next results
expected around 19 Jan 2027 (an estimate: a year ago it reported on 20 Jan 2026)
Revenue and net income per quarter. Quarter to 30 Sep 2026: revenue $19.1M, net loss $2.3M.
Quarter to 31 Dec 2021: revenue $15.3M, net income -$8.9MQuarter to 31 Dec 2021: revenue $15.3M, net income -$8.9MQuarter to 31 Mar 2022: revenue $16.1M, net income -$7.2MQuarter to 31 Mar 2022: revenue $16.1M, net income -$7.2MQuarter to 30 Jun 2022: revenue $18.7M, net income -$5.0MQuarter to 30 Jun 2022: revenue $18.7M, net income -$5.0MQuarter to 30 Sep 2022: revenue $18.7M, net income -$4.2MQuarter to 30 Sep 2022: revenue $18.7M, net income -$4.2MQuarter to 31 Dec 2022: revenue $19.3M, net income -$2.4MQuarter to 31 Dec 2022: revenue $19.3M, net income -$2.4MQuarter to 31 Mar 2023: revenue $19.7M, net income -$1.8MQuarter to 31 Mar 2023: revenue $19.7M, net income -$1.8MQuarter to 30 Jun 2023: revenue $18.1M, net income -$3.3MQuarter to 30 Jun 2023: revenue $18.1M, net income -$3.3MQuarter to 30 Sep 2023: revenue $23.8M, net income -$1.9MQuarter to 30 Sep 2023: revenue $23.8M, net income -$1.9MQuarter to 31 Dec 2023: revenue $22.1M, net income -$1.5MQuarter to 31 Dec 2023: revenue $22.1M, net income -$1.5MQuarter to 31 Mar 2024: revenue $22.7M, net income -$1.7MQuarter to 31 Mar 2024: revenue $22.7M, net income -$1.7MQuarter to 30 Jun 2024: revenue $25.8M, net income $343KQuarter to 30 Jun 2024: revenue $25.8M, net income $343KQuarter to 30 Sep 2024: revenue $28.3M, net income $1.7MQuarter to 30 Sep 2024: revenue $28.3M, net income $1.7MQuarter to 31 Dec 2024: revenue $24.7M, net income -$756KQuarter to 31 Dec 2024: revenue $24.7M, net income -$756KQuarter to 31 Mar 2025: revenue $18.9M, net income -$1.5MQuarter to 31 Mar 2025: revenue $18.9M, net income -$1.5MQuarter to 30 Jun 2025: revenue $16.1M, net income -$1.5MQuarter to 30 Jun 2025: revenue $16.1M, net income -$1.5MQuarter to 30 Sep 2025: revenue $15.9M, net income -$1.8MQuarter to 30 Sep 2025: revenue $15.9M, net income -$1.8MQuarter to 31 Dec 2025: revenue $18.3M, net income -$554KQuarter to 31 Dec 2025: revenue $18.3M, net income -$554KQuarter to 31 Mar 2026: revenue $17.3M, net income -$1.6MQuarter to 31 Mar 2026: revenue $17.3M, net income -$1.6MQuarter to 30 Jun 2026: revenue $17.8M, net income -$1.2MQuarter to 30 Jun 2026: revenue $17.8M, net income -$1.2MQuarter to 30 Sep 2026: revenue $19.1M, net income -$2.3MQuarter to 30 Sep 2026: revenue $19.1M, net income -$2.3M
31 Dec 2021RevenueNet incomeNet losstallest bar $28.3M30 Sep 2026
See the numbers
Quarter toRevenueNet income
30 Sep 2026$19.1M-$2.3M
30 Jun 2026$17.8M-$1.2M
31 Mar 2026$17.3M-$1.6M
31 Dec 2025$18.3M-$554K
30 Sep 2025$15.9M-$1.8M
30 Jun 2025$16.1M-$1.5M
31 Mar 2025$18.9M-$1.5M
31 Dec 2024$24.7M-$756K
30 Sep 2024$28.3M$1.7M
30 Jun 2024$25.8M$343K
31 Mar 2024$22.7M-$1.7M
31 Dec 2023$22.1M-$1.5M
30 Sep 2023$23.8M-$1.9M
30 Jun 2023$18.1M-$3.3M
31 Mar 2023$19.7M-$1.8M
31 Dec 2022$19.3M-$2.4M
30 Sep 2022$18.7M-$4.2M
30 Jun 2022$18.7M-$5.0M
31 Mar 2022$16.1M-$7.2M
31 Dec 2021$15.3M-$8.9M
Fundamentals, 12 months to 30 Sep 2026
MeasureLatestYear beforePeer median
RevenueSales over the last 12 months reported. $72.6M $75.6M
Revenue growthRevenue of the last 12 months compared with the 12 months before. -4.0% +11%
Net incomeProfit after all costs and taxes over the last 12 months reported. Negative is a loss. -$5.7M -$5.5M
EPS (diluted)Earnings per share: net income divided by the shares, counting options and convertibles. Left blank when the figures as filed do not fit today's share count (after a split). – –
Gross marginWhat is left of each dollar of sales after the direct cost of making the product or service. 18.1% 15.1% 73.2%
Operating marginOperating income as a share of sales: profit from the business before interest and taxes. -7.1% -6.4% -25.0%
Net marginNet income as a share of sales: what the owners keep of each dollar sold. -7.8% -7.3% -18.2%
Return on equityNet income of the last 12 months divided by shareholders' equity (the average of the latest balance sheet and the one a year earlier): the profit made on the owners' money. -16.1% -58.8%
Free cash flowCash from operations minus capital spending over the last 12 months: cash the business produced. $828K -$2.9M
CashCash, cash equivalents and short-term investments on the latest balance sheet. $22.5M $23.7M
DebtShort- and long-term borrowings on the latest balance sheet. Operating leases are not counted. $9.1M $9.2M
Net debtDebt minus cash. Negative means the company holds more cash than it owes (net cash). -$13.5M (net cash) -$14.5M
Debt to equityDebt divided by shareholders' equity on the latest balance sheet: how much is borrowed for each dollar the owners have in the company. Blank when equity is negative. 0.27 0.0
Book value per shareShareholders' equity (assets minus liabilities) on the latest balance sheet divided by the shares outstanding. –
P/EPrice to earnings: market cap divided by net income of the last 12 months. What investors pay for one dollar of yearly profit. Blank when the company made a loss. loss 19.3
P/SPrice to sales: market cap divided by revenue of the last 12 months. 0.32 5.0
EV/SalesEnterprise value (market cap plus debt minus cash) divided by revenue of the last 12 months. 0.13 5.0
P/BPrice to book: market cap divided by shareholders' equity on the latest balance sheet. Blank when equity is negative. 0.70 2.0

Latest = 12 months to 30 Sep 2026; balance-sheet lines at its end. Peer median: companies in the same industry (SIC code), or the sector when the industry is small.

Peers nearest by market cap, its own industry first

CompanyMarket capP/EP/SRevenue growthNet margin
Rockwell MedicalRMTI (this company) $23.1Mloss0.32-4.0%-7.8%
Incannex HealthcareIXHL $23.3Mloss–––
ABVC BioPharmaABVC $23.4Mloss–––
ScynexisSCYX $23.7Mloss1.3+544%-53.5%
CervoMedCRVO $22.1Mlossover 999-100%–
Aardvark TherapeuticsAARD $20.2Mloss–––

Insider Buy/Sell Shares the company's insiders (directors, officers and owners of 10% or more) bought minus what they sold on the open market in the last 90 days, from their Form 4 filings.

-$8K

bought $0, sold $8K

Institutional holders The number of institutional investment managers (13F filers: funds, pensions, asset managers) reporting the stock, compared with the quarter before. 13F reports are public 45 days after quarter end and show long positions only.

-27%

27 13F filers vs 37

Institutional ownership Shares held by 13F filers at the latest quarter end, divided by the shares outstanding in the company's latest filing. Above 100% usually means a stale share count or double counting, and is marked.

–

No 13F holdings or share count.

Short interest Shares sold short and not yet bought back, divided by the shares outstanding in the company's latest filing. From FINRA's latest short interest report: FINRA reports twice a month and publishes 7 business days after the settlement date. Above 100% means a stale share count, and is marked.

–

36K shares sold short (30 Oct 2026); no share count in the company's filings in our data

Days to cover Short interest divided by the stock's average daily trading volume, as FINRA publishes it: how many days of normal trading it would take short sellers to buy back every share. Latest report.

1.4

36K shares sold short (30 Oct 2026) divided by the stock's average daily volume, as FINRA publishes it

Short interest change How the number of shares sold short changed between FINRA's two latest reports, about two weeks apart.

-49%

70K shares sold short in the report before, 36K on 30 Oct 2026

Short sale volume Share of the stock's latest daily volume on FINRA-reported off-exchange venues that was sold short. Market makers sell short routinely, so 40% to 50% is normal; compare it with the company's own 1-year average in the cell's details. A daily flow, not short interest.

64%

64% of off-exchange volume on 20 Nov 2026 was short sales; 1-year average 48%

Open jobs Job postings open on the company's own careers site today, where we track it. Blank when we do not track this company's careers site yet.

–

We do not track this company's careers site yet.

Open jobs change How the number of open job postings changed over the last 30 days: total hiring demand, any job, any country. Shown only once we have tracked the company for 30 days.

–

We do not track this company's careers site yet.

Employees Total staff the company reported in its latest annual report (10-K), with the change from the year before when both years are reported.

–

No headcount in its annual reports in our data.

Visa hiring (foreign workers) Applications to hire foreign specialists on H-1B and E-3 visas certified by the Labor Department in the last 12 months, compared with the 12 months before. This is NOT total hiring: most hires need no visa. Open jobs shows total hiring where we track it.

–

No data for this company

Revenue growth Sales in the latest reported quarter compared with the same quarter a year earlier.

+20%

$19.1M vs $15.9M (quarter ended 30 Sep 2026)

Capital spending Money spent on buildings, machines and equipment in the latest quarter, compared with the same quarter a year earlier.

–

No data for this company

Federal contracts Money the US government committed to the company in contracts and grants over the last 12 months.

–

No data for this company

Lobbying What the company reported spending on federal lobbying over the last four quarters.

–

No data for this company

Layoff notices Workers named in state WARN layoff notices over the last 12 months (employers must file them 60 days before a large layoff).

–

No data for this company

News (7d) Articles about the company published in the last 7 days, from our Google News collection (one search per company, every half hour). Blank when we do not collect news for this company.

4

4 articles in the last 7 days; its usual week has 0 (the median of the 26 weeks before).

News vs usual Articles in the last 7 days divided by the company's usual week: the median week of the 26 weeks before. Blank when the usual week has fewer than one article.

–

4 articles in the last 7 days; its usual week has 0: fewer than one, so there is nothing to compare with.

Price $5.82 on 20 Nov 2026, -32% over 12 months (12-month range $5.19 to $12.60)

  • Sharp change
  • 8-K and other filings
Insider net buying (open market). Insiders sold a net $12K in the last 12 months (the 12 months before: $47K).
Revenue per quarter. Revenue $19.1M in the latest quarter, +20% on a year earlier.
Capital spending per quarter. Capital spending $722K in the latest quarter, +215% on a year earlier.
Institutional holders (13F filers). 27 13F filers reported holding it in the latest 13F quarter, -25% on a year earlier.

Every point sits on the day the fact became public (filing acceptance or publication), not the day it happened; prices through 20 Nov 2026. Hover or tap a marker for the fact; click it for the evidence or the source. No data here for: h-1b/e-3 applications certified, federal obligations, lobbying spend, workers in warn layoff notices.

See the numbers
Dated facts on the price chart (newest 100)
Became publicKindFact
8 May 20268-K and other filingsDelisting notice or listing transfer
18 Nov 20258-K and other filingsDirector or officer change
29 Sep 20258-K and other filingsDirector or officer change
29 Sep 2025Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
12 Dec 20248-K and other filingsDirector or officer change
12 Dec 2024Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
3 Dec 2024Sharp changeShort interest spike: short interest spike, 1.1M vs usual 624K (2024-11-15); 1.3x the same period a year earlier
19 Nov 2024Sharp changeMany funds opening a new position: many funds opening a new position, 21 vs usual 4.50 (2024-09-30); 3.0x the same period a year earlier
13 Aug 2024Sharp changeQuarterly revenue change: quarterly revenue change, 25.8M vs usual 19.5M (2024-06-30); 1.4x the same period a year earlier
28 Nov 2023Sharp changeShort interest spike: short interest spike, 885K vs usual 169K (2023-11-15); 6.9x the same period a year earlier
14 Nov 2023Sharp changeShort interest spike: short interest spike, 996K vs usual 147K (2023-10-31); 10.1x the same period a year earlier
31 Oct 2023Sharp changeShort interest spike: short interest spike, 919K vs usual 135K (2023-10-13); 9.4x the same period a year earlier
17 Oct 2023Sharp changeShort interest spike: short interest spike, 814K vs usual 117K (2023-09-29); 9.2x the same period a year earlier
17 Oct 20238-K and other filingsDirector or officer change
3 Oct 2023Sharp changeShort interest spike: short interest spike, 889K vs usual 110K (2023-09-15); 7.8x the same period a year earlier
19 Sep 2023Sharp changeShort interest spike: short interest spike, 1.1M vs usual 104K (2023-08-31); 11.2x the same period a year earlier
15 Sep 20238-K and other filingsDirector or officer change
15 Sep 2023Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
29 Aug 2023Sharp changeShort interest spike: short interest spike, 1.3M vs usual 104K (2023-08-15); 5.7x the same period a year earlier
15 Aug 2023Sharp changeShort interest spike: short interest spike, 1.5M vs usual 104K (2023-07-31); 9.7x the same period a year earlier
1 Aug 2023Sharp changeShort interest spike: short interest spike, 1.3M vs usual 104K (2023-07-14); 6.6x the same period a year earlier
18 Jul 2023Sharp changeShort interest spike: short interest spike, 721K vs usual 104K (2023-06-30); 3.5x the same period a year earlier
13 Apr 20238-K and other filingsChanged its auditor
22 Jun 20228-K and other filingsRegistered new securities for sale (S-1)
22 Jun 20228-K and other filingsDirector or officer change
22 Jun 2022Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
31 Mar 20228-K and other filingsReport will be filed late
21 Mar 20228-K and other filingsDirector or officer change
18 Mar 20228-K and other filingsDirector or officer change
18 Mar 2022Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
10 Dec 20218-K and other filingsDelisting notice or listing transfer
Insider net buying (open market)
Month from 1 Oct 2024: -$12K published
Month from 1 Nov 2024: -$70K published
Month from 1 Jan 2025: -$7K published
Month from 1 Apr 2025: $83K published
Month from 1 Jul 2025: -$9K published
Month from 1 Oct 2025: -$16K published
Month from 1 Nov 2025: -$4K published
Month from 1 Jan 2026: -$3K published
Month from 1 Oct 2026: -$8K published
Revenue per quarter
Quarter ended 31 Dec 2021: $15.3M, +1.1% on a year earlier; public on 9 Apr 2022
Quarter ended 31 Mar 2022: $16.1M, +4.2% on a year earlier; public on 17 May 2022
Quarter ended 30 Jun 2022: $18.7M, +23% on a year earlier; public on 16 Aug 2022
Quarter ended 30 Sep 2022: $18.7M, +17% on a year earlier; public on 15 Nov 2022
Quarter ended 31 Dec 2022: $19.3M, +26% on a year earlier; public on 31 Mar 2023
Quarter ended 31 Mar 2023: $19.7M, +22% on a year earlier; public on 16 May 2023
Quarter ended 30 Jun 2023: $18.1M, -3.2% on a year earlier; public on 15 Aug 2023
Quarter ended 30 Sep 2023: $23.8M, +27% on a year earlier; public on 15 Nov 2023
Quarter ended 31 Dec 2023: $22.1M, +14% on a year earlier; public on 22 Mar 2024
Quarter ended 31 Mar 2024: $22.7M, +15% on a year earlier; public on 15 May 2024
Quarter ended 30 Jun 2024: $25.8M, +43% on a year earlier; public on 9 Aug 2024
Quarter ended 30 Sep 2024: $28.3M, +19% on a year earlier; public on 13 Nov 2024
Quarter ended 31 Dec 2024: $24.7M, +12% on a year earlier; public on 21 Mar 2025
Quarter ended 31 Mar 2025: $18.9M, -17% on a year earlier; public on 13 May 2025
Quarter ended 30 Jun 2025: $16.1M, -38% on a year earlier; public on 15 Aug 2025
Quarter ended 30 Sep 2025: $15.9M, -44% on a year earlier; public on 13 Nov 2025
Quarter ended 31 Dec 2025: $18.3M, -26% on a year earlier; public on 27 Mar 2026
Quarter ended 31 Mar 2026: $17.3M, -8.3% on a year earlier; public on 8 May 2026
Quarter ended 30 Jun 2026: $17.8M, +11% on a year earlier; public on 14 Aug 2026
Quarter ended 30 Sep 2026: $19.1M, +20% on a year earlier; public on 13 Nov 2026
Capital spending per quarter
Quarter ended 31 Mar 2024: $139K; public on 13 May 2025
Quarter ended 30 Jun 2024: $286K; public on 15 Aug 2025
Quarter ended 31 Dec 2024: $395K; public on 21 Mar 2025
Quarter ended 31 Mar 2025: $63K, -55% on a year earlier; public on 13 May 2025
Quarter ended 30 Jun 2025: $164K, -43% on a year earlier; public on 15 Aug 2025
Quarter ended 30 Sep 2025: $229K; public on 13 Nov 2025
Quarter ended 31 Dec 2025: $86K, -78% on a year earlier; public on 27 Mar 2026
Quarter ended 31 Mar 2026: $425K, +575% on a year earlier; public on 8 May 2026
Quarter ended 30 Jun 2026: $617K, +276% on a year earlier; public on 14 Aug 2026
Quarter ended 30 Sep 2026: $722K, +215% on a year earlier; public on 13 Nov 2026
Institutional holders (13F filers)
31 Dec 2021 report: 55; public on 14 Feb 2022
31 Mar 2022 report: 54; public on 16 May 2022
30 Jun 2022 report: 35; public on 15 Aug 2022
30 Sep 2022 report: 32; public on 14 Nov 2022
31 Dec 2022 report: 31; public on 14 Feb 2023
31 Mar 2023 report: 31; public on 15 May 2023
30 Jun 2023 report: 38; public on 14 Aug 2023
30 Sep 2023 report: 28; public on 14 Nov 2023
31 Dec 2023 report: 31; public on 14 Feb 2024
31 Mar 2024 report: 32; public on 15 May 2024
30 Jun 2024 report: 27; public on 14 Aug 2024
30 Sep 2024 report: 50; public on 14 Nov 2024
31 Dec 2024 report: 51; public on 14 Feb 2025
31 Mar 2025 report: 44; public on 15 May 2025
30 Jun 2025 report: 40; public on 14 Aug 2025
30 Sep 2025 report: 36; public on 14 Nov 2025
31 Dec 2025 report: 35; public on 17 Feb 2026
31 Mar 2026 report: 42; public on 15 May 2026
30 Jun 2026 report: 37; public on 14 Aug 2026
30 Sep 2026 report: 27; public on 16 Nov 2026

What is unusual now

  • Nothing unusual in the last 90 days: no change appeared. Its most unusual measure now is research and development expense, quarter at $114K (30 Sep 2026), 228× its normal quarter; higher than 17% of its own history.
  • Insider net buying (open market): Insiders sold a net $12K in the last 12 months (the 12 months before: $47K).
  • Revenue per quarter: Revenue $19.1M in the latest quarter, +20% on a year earlier.
  • Capital spending per quarter: Capital spending $722K in the latest quarter, +215% on a year earlier.

Latest records

The names and amounts behind the totals, newest first

Insider trades

All 48 insider trades

Last 90 days: 1 sale, $8K; no purchases. Open-market trades by officers, directors and 10% owners.

FiledInsiderTradeSharesPriceValueSource
5 Oct 2026Mark StrobeckPresident and CEOSellplanned in advance (10b5-1)1,000$8.42$8KForm 4
5 Jan 2026Heather HunterChief Operating OfficerSellplanned in advance (10b5-1)2,868$0.84$2KForm 4
5 Jan 2026Jesse NeriSVP and CFOSellplanned in advance (10b5-1)886$0.84$744Form 4
18 Nov 2025John G CooperDirectorSell5,079$0.87$4KForm 4
8 Oct 2025Heather HunterSVP, Chief Operating OfficerSellplanned in advance (10b5-1)2,868$1.19$3KForm 4
1 Oct 2025Mark StrobeckPresident and CEOSellplanned in advance (10b5-1)6,926$1.19$8KForm 4
1 Oct 2025Timothy CholeSVP and CCOSellplanned in advance (10b5-1)2,868$1.19$3KForm 4
1 Oct 2025Jesse NeriSVP and CFOSellplanned in advance (10b5-1)886$1.19$1KForm 4

27 institutions reported shares at the end of Q3 2026; 4 opened a position, 14 sold out. From 13F reports.

InstitutionShares% of companyValueChange vs Q2 2026
Vanguard Capital Management LLC120K$1.0M-1.1M-90%
Geode Capital Management, LLC40K$339K-324K-89%
Renaissance Technologies LLC36K$306K-324K-90%
Vanguard Fiduciary Trust Co23K$199K-209K-90%
Wealthspire Advisors, LLC15K$130K-137K-90%
BlackRock, Inc.14K$121K-131K-90%
Jane Street Group, LLC11K$98K-234K-95%
Gsa Capital Partners LLP11K-59K-85%
State Street Corp10K$86K-91K-90%
UBS Group AG10K$85K-60K-86%

Company events

All 75 company events

In 12 months: 1 delisting notice, 1 major agreement. Results releases and routine reports are left out.

FiledWhat happenedSource
3 Nov 2026Signed a major agreementSame filing: sold shares privately8-K
8 May 2026Delisting notice or listing transfer8-K
18 Nov 2025Director or officer change8-K
29 Sep 2025Director or officer change8-K
12 Dec 2024Director or officer change8-K
15 Jul 2024Signed a major agreement8-K
8 Jan 2024Signed a major agreementSame filing: took on new debt, sold shares privately8-K
17 Oct 2023Director or officer change8-K

Reported lobbying spend: $50K in Q4 2018, $50K in Q3 2018. Rows are lobbying firms hired or let go; amounts are reported per quarter, not per firm here.

DateChangeLobbying firmIssueSource
31 Mar 2019EndedPolsinelli PCfor Rockwell Medical Technologies, Inc.Not statedFiling
1 Dec 2015NewPolsinelli PCfor Rockwell Medical Technologies, Inc.Issues pertaining to the coverage of hemodialysis productsMedicare/MedicaidFiling

The 5 newest of 47 articles that name the company.

Timeline

Several things at once

Two or more unrelated kinds of records unusual within 30 days

3 Dec 2024confirmed

Confirmed across sources Institutional holdings and Short interest and volume

Rockwell Medical (RMTI): saw 21 13F filers open a new position in the quarter ended 30 Sep 2024, 3.0× the same quarter last year, while it had 1.1M shares sold short in the 15 Nov 2024 report, 1.3× the same report last year. Two unrelated kinds of activity within 14 days.

  • Institutional holdings: Many funds opening a new position, became public on 14 Nov 2024
  • Short interest and volume: Short interest spike, became public on 27 Nov 2024
2022-09-30: 52022-12-31: 22023-03-31: 42023-06-30: 122023-09-30: 72023-12-31: 62024-03-31: 42024-06-30: 12024-09-30: 21
The quarter ended 30 Sep 2024 against the 8 quarters before it. this quarterearliernormal: 4.5
See the evidence (2 changes)

Institutional holdings: Many funds opening a new position became public on 14 Nov 2024

Rockwell Medical saw 21 13F filers open a new position in the quarter ended 30 Sep 2024, 3.0× the same quarter last year.

This period
21 (the quarter ended 30 Sep 2024)
Normal quarter (median of 8 earlier)
4.5
Typical spread (median absolute deviation)
2
How far from its usual level
+5.5
Same quarter last year
7
History used
4,018 days
2022-09-30: 52022-12-31: 22023-03-31: 42023-06-30: 122023-09-30: 72023-12-31: 62024-03-31: 42024-06-30: 12024-09-30: 21
the quarter ended 30 Sep 20248 earlier quartersnormal: 4.5

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 6+ earlier periods, 730+ days of history and a value of at least 20.

Check it at the source: SEC Form 13F data sets.

Short interest and volume: Short interest spike became public on 27 Nov 2024

Rockwell Medical had 1.1M shares sold short in the 15 Nov 2024 report, 1.3× the same report last year.

This period
1.1M (the 15 Nov 2024 report)
Normal report (median of 24 earlier)
624K
Typical spread (median absolute deviation)
80K
How far from its usual level
+4.1
Same report last year
885K
History used
2,513 days
2023-11-15: 885K2023-11-30: 812K2023-12-15: 767K2023-12-29: 589K2024-01-12: 601K2024-01-31: 539K2024-02-15: 619K2024-02-29: 629K2024-03-15: 570K2024-03-28: 676K2024-04-15: 638K2024-04-30: 617K2024-05-15: 633K2024-05-31: 674K2024-06-14: 700K2024-06-28: 740K2024-07-15: 597K2024-07-31: 485K2024-08-15: 430K2024-08-30: 322K2024-09-13: 398K2024-09-30: 527K2024-10-15: 823K2024-10-31: 894K2024-11-15: 1.1M
the 15 Nov 2024 report24 earlier reportsnormal: 624K

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

Check it at the source: FINRA short interest data.

Several things at once means two or more unrelated kinds of records changed sharply within 30 days. Records that come from the same documents (for example filings and the financials taken from them) count as one kind.

20 Aug 2019confirmed

Confirmed across sources Insiders and Institutional holdings

Rockwell Medical (RMTI): had 3 insiders buy $566K of its shares on the open market within 30 days (4 filings), while it saw 24 13F filers open a new position in the quarter ended 30 Jun 2019, 3.0× the same quarter last year. Two unrelated kinds of activity within 27 days.

  • Insiders: Clustered insider buying, became public on 24 Jul 2019
  • Institutional holdings: Many funds opening a new position, became public on 14 Aug 2019
2017-06-30: 82017-09-30: 32017-12-31: 32018-03-31: 82018-06-30: 82018-09-30: 52018-12-31: 82019-03-31: 82019-06-30: 24
The quarter ended 30 Jun 2019 against the 8 quarters before it. this quarterearliernormal: 8
See the evidence (2 changes)

Insiders: Clustered insider buying became public on 24 Jul 2019

Rockwell Medical had 3 insiders buy $566K of its shares on the open market within 30 days (4 filings).

Independent buyers
3
Purchase filings (Form 4, code P)
4
Total bought
$566K
Window
24 Jun 2019 to 24 Jul 2019
  • Paul Stuart M (Chief Executive Officer) bought 10,000 shares of RMTI ($29,700)dated 2 Jul 2019, public 3 Jul 2019
  • Smith Angus W. (Chief Financial Officer) bought 10,000 shares of RMTI ($30,600)dated 2 Jul 2019, public 3 Jul 2019
  • Curfman Matthew J. (See Footnotes 1 and 2) and 8 other(s) bought 9,780 shares of RMTI ($29,829)dated 10 Jul 2019, public 11 Jul 2019
  • Richmond Brothers 401(k) Profit Sharing Plan (See Footnotes 1 and 2) and 8 other(s) bought 161,457 shares of RMTI ($475,881)dated 23 Jul 2019, public 24 Jul 2019

Fires when at least 3 independent insiders (joint filers count once) buy on the open market in 30 days, in at least 2 filings, for $100K or more in total; amendments do not count.

Institutional holdings: Many funds opening a new position became public on 14 Aug 2019

Rockwell Medical saw 24 13F filers open a new position in the quarter ended 30 Jun 2019, 3.0× the same quarter last year.

This period
24 (the quarter ended 30 Jun 2019)
Normal quarter (median of 8 earlier)
8
Typical spread (median absolute deviation)
0
How far from its usual level
+5.3
Same quarter last year
8
History used
2,099 days
2017-06-30: 82017-09-30: 32017-12-31: 32018-03-31: 82018-06-30: 82018-09-30: 52018-12-31: 82019-03-31: 82019-06-30: 24
the quarter ended 30 Jun 20198 earlier quartersnormal: 8

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 6+ earlier periods, 730+ days of history and a value of at least 20.

Check it at the source: SEC Form 13F data sets.

Several things at once means two or more unrelated kinds of records changed sharply within 30 days. Records that come from the same documents (for example filings and the financials taken from them) count as one kind.

Timeline

Changes and notable records, by the date each became public

  1. 8 May 2026Filings record

    Delisting notice or listing transfer

  2. 18 Nov 2025Filings record

    Director or officer change

  3. 29 Sep 2025Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  4. 29 Sep 2025Filings record

    Director or officer change

  5. 16 Apr 2025Insiders record

    Irrevocable Larson Family Investment Trust (ten percent owner) bought 87,500 shares of RMTI ($94,055) (dated 15 Apr 2025)

  6. 12 Dec 2024Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  7. 12 Dec 2024Filings record

    Director or officer change

  8. 3 Dec 2024several at once

    saw 21 13F filers open a new position in the quarter ended 30 Sep 2024, 3.0× the same quarter last year, while it had 1.1M shares sold short in the 15 Nov 2024 report, 1.3× the same report last year. Two unrelated kinds of activity within 14 days.

    See the evidence (2 changes)

    Institutional holdings: Many funds opening a new position became public on 14 Nov 2024

    Rockwell Medical saw 21 13F filers open a new position in the quarter ended 30 Sep 2024, 3.0× the same quarter last year.

    This period
    21 (the quarter ended 30 Sep 2024)
    Normal quarter (median of 8 earlier)
    4.5
    Typical spread (median absolute deviation)
    2
    How far from its usual level
    +5.5
    Same quarter last year
    7
    History used
    4,018 days
    2022-09-30: 52022-12-31: 22023-03-31: 42023-06-30: 122023-09-30: 72023-12-31: 62024-03-31: 42024-06-30: 12024-09-30: 21
    the quarter ended 30 Sep 20248 earlier quartersnormal: 4.5

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 6+ earlier periods, 730+ days of history and a value of at least 20.

    Check it at the source: SEC Form 13F data sets.

    Short interest and volume: Short interest spike became public on 27 Nov 2024

    Rockwell Medical had 1.1M shares sold short in the 15 Nov 2024 report, 1.3× the same report last year.

    This period
    1.1M (the 15 Nov 2024 report)
    Normal report (median of 24 earlier)
    624K
    Typical spread (median absolute deviation)
    80K
    How far from its usual level
    +4.1
    Same report last year
    885K
    History used
    2,513 days
    2023-11-15: 885K2023-11-30: 812K2023-12-15: 767K2023-12-29: 589K2024-01-12: 601K2024-01-31: 539K2024-02-15: 619K2024-02-29: 629K2024-03-15: 570K2024-03-28: 676K2024-04-15: 638K2024-04-30: 617K2024-05-15: 633K2024-05-31: 674K2024-06-14: 700K2024-06-28: 740K2024-07-15: 597K2024-07-31: 485K2024-08-15: 430K2024-08-30: 322K2024-09-13: 398K2024-09-30: 527K2024-10-15: 823K2024-10-31: 894K2024-11-15: 1.1M
    the 15 Nov 2024 report24 earlier reportsnormal: 624K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

    Several things at once means two or more unrelated kinds of records changed sharply within 30 days. Records that come from the same documents (for example filings and the financials taken from them) count as one kind.

  9. 27 Nov 2024Short interest and volume change

    had 1.1M shares sold short in the 15 Nov 2024 report, 1.3× the same report last year.

    Same report last year: 885K; its normal report is 624K.

    See the evidence
    This period
    1.1M (the 15 Nov 2024 report)
    Normal report (median of 24 earlier)
    624K
    Typical spread (median absolute deviation)
    80K
    How far from its usual level
    +4.1
    Same report last year
    885K
    History used
    2,513 days
    2023-11-15: 885K2023-11-30: 812K2023-12-15: 767K2023-12-29: 589K2024-01-12: 601K2024-01-31: 539K2024-02-15: 619K2024-02-29: 629K2024-03-15: 570K2024-03-28: 676K2024-04-15: 638K2024-04-30: 617K2024-05-15: 633K2024-05-31: 674K2024-06-14: 700K2024-06-28: 740K2024-07-15: 597K2024-07-31: 485K2024-08-15: 430K2024-08-30: 322K2024-09-13: 398K2024-09-30: 527K2024-10-15: 823K2024-10-31: 894K2024-11-15: 1.1M
    the 15 Nov 2024 report24 earlier reportsnormal: 624K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  10. 14 Nov 2024Institutional holdings change

    saw 21 13F filers open a new position in the quarter ended 30 Sep 2024, 3.0× the same quarter last year.

    Same quarter last year: 7; its normal quarter is 4.5.

    See the evidence
    This period
    21 (the quarter ended 30 Sep 2024)
    Normal quarter (median of 8 earlier)
    4.5
    Typical spread (median absolute deviation)
    2
    How far from its usual level
    +5.5
    Same quarter last year
    7
    History used
    4,018 days
    2022-09-30: 52022-12-31: 22023-03-31: 42023-06-30: 122023-09-30: 72023-12-31: 62024-03-31: 42024-06-30: 12024-09-30: 21
    the quarter ended 30 Sep 20248 earlier quartersnormal: 4.5

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 6+ earlier periods, 730+ days of history and a value of at least 20.

    Check it at the source: SEC Form 13F data sets.

  11. 13 Aug 2024Financials change

    reported revenue of $25.8M for the quarter ended 30 Jun 2024, 1.4× the same quarter last year.

    Same quarter last year: $18.1M; its normal quarter is $19.5M.

    See the evidence
    This period
    $25.8M (the quarter ended 30 Jun 2024)
    Normal quarter (median of 8 earlier)
    $19.5M
    Typical spread (median absolute deviation)
    $1.1M
    How far from its usual level
    +3.3
    Same quarter last year
    $18.1M
    History used
    5,114 days
    2022-06-30: $18.7M2022-09-30: $18.7M2022-12-31: $19.3M2023-03-31: $19.7M2023-06-30: $18.1M2023-09-30: $23.8M2023-12-31: $22.1M2024-03-31: $22.7M2024-06-30: $25.8M
    the quarter ended 30 Jun 20248 earlier quartersnormal: $19.5M

    Fires when the period is at least 3.0 robust standard deviations above the company's own median, with 6+ earlier periods, 540+ days of history and a value of at least $10.0M.

    Check it at the source: SEC EDGAR quarterly reports.

  12. 28 Nov 2023Short interest and volume change

    had 885K shares sold short in the 15 Nov 2023 report, 6.9× the same report last year.

    Same report last year: 128K; its normal report is 169K.

    See the evidence
    This period
    885K (the 15 Nov 2023 report)
    Normal report (median of 24 earlier)
    169K
    Typical spread (median absolute deviation)
    106K
    How far from its usual level
    +4.5
    Same report last year
    128K
    History used
    2,147 days
    2022-11-15: 128K2022-11-30: 76K2022-12-15: 75K2022-12-30: 75K2023-01-13: 77K2023-01-31: 89K2023-02-15: 186K2023-02-28: 153K2023-03-15: 187K2023-03-31: 141K2023-04-14: 107K2023-04-28: 66K2023-05-15: 61K2023-05-31: 39K2023-06-15: 281K2023-06-30: 721K2023-07-14: 1.3M2023-07-31: 1.5M2023-08-15: 1.3M2023-08-31: 1.1M2023-09-15: 889K2023-09-29: 814K2023-10-13: 919K2023-10-31: 996K2023-11-15: 885K
    the 15 Nov 2023 report24 earlier reportsnormal: 169K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  13. 10 Nov 2023Short interest and volume change

    had 996K shares sold short in the 31 Oct 2023 report, 10× the same report last year.

    Same report last year: 99K; its normal report is 147K.

    See the evidence
    This period
    996K (the 31 Oct 2023 report)
    Normal report (median of 24 earlier)
    147K
    Typical spread (median absolute deviation)
    77K
    How far from its usual level
    +7.4
    Same report last year
    99K
    History used
    2,132 days
    2022-10-31: 99K2022-11-15: 128K2022-11-30: 76K2022-12-15: 75K2022-12-30: 75K2023-01-13: 77K2023-01-31: 89K2023-02-15: 186K2023-02-28: 153K2023-03-15: 187K2023-03-31: 141K2023-04-14: 107K2023-04-28: 66K2023-05-15: 61K2023-05-31: 39K2023-06-15: 281K2023-06-30: 721K2023-07-14: 1.3M2023-07-31: 1.5M2023-08-15: 1.3M2023-08-31: 1.1M2023-09-15: 889K2023-09-29: 814K2023-10-13: 919K2023-10-31: 996K
    the 31 Oct 2023 report24 earlier reportsnormal: 147K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  14. 25 Oct 2023Short interest and volume change

    had 919K shares sold short in the 13 Oct 2023 report, 9.4× the same report last year.

    Same report last year: 98K; its normal report is 135K.

    See the evidence
    This period
    919K (the 13 Oct 2023 report)
    Normal report (median of 24 earlier)
    135K
    Typical spread (median absolute deviation)
    59K
    How far from its usual level
    +8.9
    Same report last year
    98K
    History used
    2,114 days
    2022-10-14: 98K2022-10-31: 99K2022-11-15: 128K2022-11-30: 76K2022-12-15: 75K2022-12-30: 75K2023-01-13: 77K2023-01-31: 89K2023-02-15: 186K2023-02-28: 153K2023-03-15: 187K2023-03-31: 141K2023-04-14: 107K2023-04-28: 66K2023-05-15: 61K2023-05-31: 39K2023-06-15: 281K2023-06-30: 721K2023-07-14: 1.3M2023-07-31: 1.5M2023-08-15: 1.3M2023-08-31: 1.1M2023-09-15: 889K2023-09-29: 814K2023-10-13: 919K
    the 13 Oct 2023 report24 earlier reportsnormal: 135K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  15. 17 Oct 2023Filings record

    Director or officer change

  16. 12 Oct 2023Short interest and volume change

    had 814K shares sold short in the 29 Sep 2023 report, 9.2× the same report last year.

    Same report last year: 88K; its normal report is 117K.

    See the evidence
    This period
    814K (the 29 Sep 2023 report)
    Normal report (median of 24 earlier)
    117K
    Typical spread (median absolute deviation)
    47K
    How far from its usual level
    +10.0
    Same report last year
    88K
    History used
    2,100 days
    2022-09-30: 88K2022-10-14: 98K2022-10-31: 99K2022-11-15: 128K2022-11-30: 76K2022-12-15: 75K2022-12-30: 75K2023-01-13: 77K2023-01-31: 89K2023-02-15: 186K2023-02-28: 153K2023-03-15: 187K2023-03-31: 141K2023-04-14: 107K2023-04-28: 66K2023-05-15: 61K2023-05-31: 39K2023-06-15: 281K2023-06-30: 721K2023-07-14: 1.3M2023-07-31: 1.5M2023-08-15: 1.3M2023-08-31: 1.1M2023-09-15: 889K2023-09-29: 814K
    the 29 Sep 2023 report24 earlier reportsnormal: 117K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  17. 27 Sep 2023Short interest and volume change

    had 889K shares sold short in the 15 Sep 2023 report, 7.8× the same report last year.

    Same report last year: 114K; its normal report is 110K.

    See the evidence
    This period
    889K (the 15 Sep 2023 report)
    Normal report (median of 24 earlier)
    110K
    Typical spread (median absolute deviation)
    39K
    How far from its usual level
    +13.4
    Same report last year
    114K
    History used
    2,086 days
    2022-09-15: 114K2022-09-30: 88K2022-10-14: 98K2022-10-31: 99K2022-11-15: 128K2022-11-30: 76K2022-12-15: 75K2022-12-30: 75K2023-01-13: 77K2023-01-31: 89K2023-02-15: 186K2023-02-28: 153K2023-03-15: 187K2023-03-31: 141K2023-04-14: 107K2023-04-28: 66K2023-05-15: 61K2023-05-31: 39K2023-06-15: 281K2023-06-30: 721K2023-07-14: 1.3M2023-07-31: 1.5M2023-08-15: 1.3M2023-08-31: 1.1M2023-09-15: 889K
    the 15 Sep 2023 report24 earlier reportsnormal: 110K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  18. 15 Sep 2023Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  19. 15 Sep 2023Filings record

    Director or officer change

  20. 13 Sep 2023Short interest and volume change

    had 1.1M shares sold short in the 31 Aug 2023 report, 11× the same report last year.

    Same report last year: 100K; its normal report is 104K.

    See the evidence
    This period
    1.1M (the 31 Aug 2023 report)
    Normal report (median of 24 earlier)
    104K
    Typical spread (median absolute deviation)
    33K
    How far from its usual level
    +20.4
    Same report last year
    100K
    History used
    2,071 days
    2022-08-31: 100K2022-09-15: 114K2022-09-30: 88K2022-10-14: 98K2022-10-31: 99K2022-11-15: 128K2022-11-30: 76K2022-12-15: 75K2022-12-30: 75K2023-01-13: 77K2023-01-31: 89K2023-02-15: 186K2023-02-28: 153K2023-03-15: 187K2023-03-31: 141K2023-04-14: 107K2023-04-28: 66K2023-05-15: 61K2023-05-31: 39K2023-06-15: 281K2023-06-30: 721K2023-07-14: 1.3M2023-07-31: 1.5M2023-08-15: 1.3M2023-08-31: 1.1M
    the 31 Aug 2023 report24 earlier reportsnormal: 104K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  21. 25 Aug 2023Short interest and volume change

    had 1.3M shares sold short in the 15 Aug 2023 report, 5.7× the same report last year.

    Same report last year: 227K; its normal report is 104K.

    See the evidence
    This period
    1.3M (the 15 Aug 2023 report)
    Normal report (median of 24 earlier)
    104K
    Typical spread (median absolute deviation)
    33K
    How far from its usual level
    +23.7
    Same report last year
    227K
    History used
    2,055 days
    2022-08-15: 227K2022-08-31: 100K2022-09-15: 114K2022-09-30: 88K2022-10-14: 98K2022-10-31: 99K2022-11-15: 128K2022-11-30: 76K2022-12-15: 75K2022-12-30: 75K2023-01-13: 77K2023-01-31: 89K2023-02-15: 186K2023-02-28: 153K2023-03-15: 187K2023-03-31: 141K2023-04-14: 107K2023-04-28: 66K2023-05-15: 61K2023-05-31: 39K2023-06-15: 281K2023-06-30: 721K2023-07-14: 1.3M2023-07-31: 1.5M2023-08-15: 1.3M
    the 15 Aug 2023 report24 earlier reportsnormal: 104K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  22. 10 Aug 2023Short interest and volume change

    had 1.5M shares sold short in the 31 Jul 2023 report, 9.7× the same report last year.

    Same report last year: 157K; its normal report is 104K.

    See the evidence
    This period
    1.5M (the 31 Jul 2023 report)
    Normal report (median of 24 earlier)
    104K
    Typical spread (median absolute deviation)
    33K
    How far from its usual level
    +28.6
    Same report last year
    157K
    History used
    2,040 days
    2022-07-29: 157K2022-08-15: 227K2022-08-31: 100K2022-09-15: 114K2022-09-30: 88K2022-10-14: 98K2022-10-31: 99K2022-11-15: 128K2022-11-30: 76K2022-12-15: 75K2022-12-30: 75K2023-01-13: 77K2023-01-31: 89K2023-02-15: 186K2023-02-28: 153K2023-03-15: 187K2023-03-31: 141K2023-04-14: 107K2023-04-28: 66K2023-05-15: 61K2023-05-31: 39K2023-06-15: 281K2023-06-30: 721K2023-07-14: 1.3M2023-07-31: 1.5M
    the 31 Jul 2023 report24 earlier reportsnormal: 104K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  23. 26 Jul 2023Short interest and volume change

    had 1.3M shares sold short in the 14 Jul 2023 report, 6.6× the same report last year.

    Same report last year: 197K; its normal report is 104K.

    See the evidence
    This period
    1.3M (the 14 Jul 2023 report)
    Normal report (median of 24 earlier)
    104K
    Typical spread (median absolute deviation)
    33K
    How far from its usual level
    +24.1
    Same report last year
    197K
    History used
    2,023 days
    2022-07-15: 197K2022-07-29: 157K2022-08-15: 227K2022-08-31: 100K2022-09-15: 114K2022-09-30: 88K2022-10-14: 98K2022-10-31: 99K2022-11-15: 128K2022-11-30: 76K2022-12-15: 75K2022-12-30: 75K2023-01-13: 77K2023-01-31: 89K2023-02-15: 186K2023-02-28: 153K2023-03-15: 187K2023-03-31: 141K2023-04-14: 107K2023-04-28: 66K2023-05-15: 61K2023-05-31: 39K2023-06-15: 281K2023-06-30: 721K2023-07-14: 1.3M
    the 14 Jul 2023 report24 earlier reportsnormal: 104K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  24. 13 Jul 2023Short interest and volume change

    had 721K shares sold short in the 30 Jun 2023 report, 3.5× the same report last year.

    Same report last year: 207K; its normal report is 104K.

    See the evidence
    This period
    721K (the 30 Jun 2023 report)
    Normal report (median of 24 earlier)
    104K
    Typical spread (median absolute deviation)
    33K
    How far from its usual level
    +12.4
    Same report last year
    207K
    History used
    2,009 days
    2022-06-30: 207K2022-07-15: 197K2022-07-29: 157K2022-08-15: 227K2022-08-31: 100K2022-09-15: 114K2022-09-30: 88K2022-10-14: 98K2022-10-31: 99K2022-11-15: 128K2022-11-30: 76K2022-12-15: 75K2022-12-30: 75K2023-01-13: 77K2023-01-31: 89K2023-02-15: 186K2023-02-28: 153K2023-03-15: 187K2023-03-31: 141K2023-04-14: 107K2023-04-28: 66K2023-05-15: 61K2023-05-31: 39K2023-06-15: 281K2023-06-30: 721K
    the 30 Jun 2023 report24 earlier reportsnormal: 104K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  25. 13 Apr 2023Filings record

    Changed its auditor

  26. 22 Jun 2022Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  27. 22 Jun 2022Filings record

    Registered new securities for sale (S-1)

  28. 22 Jun 2022Filings record

    Director or officer change

  29. 31 Mar 2022Filings record

    Report will be filed late

  30. 21 Mar 2022Filings record

    Director or officer change

  31. 18 Mar 2022Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  32. 18 Mar 2022Filings record

    Director or officer change

  33. 10 Dec 2021Filings record

    Delisting notice or listing transfer

  34. 17 Jun 2021Filings record

    Delisting notice or listing transfer

  35. 25 Jan 2021Filings record

    Director or officer change

  36. 15 Dec 2020Filings record

    Director or officer change

  37. 17 Sep 2020Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  38. 17 Sep 2020Filings record

    Director or officer change (dated 16 Sep 2020)

  39. 3 Jul 2020Insiders record

    RBI PI Manager, LLC (See Footnotes 1 and 2) and 8 other(s) bought 24,681 shares of RMTI ($47,563) (dated 2 Jul 2020)

  40. 10 Jun 2020Filings record

    Director or officer change

Showing the newest 40 of 90 entries; narrow the window or the kind of data to see older ones.

Not listed: 184 routine records (quarterly and annual reports, results releases, other 8-K items, material agreements and individual insider sales), counted over all history.

Identifiers and sources

How records are matched to this company, and what each source holds for it

Cik
0001041024
Ticker
RMTI
Domain
rockwellmed.com
Hq location
MI|WIXOM|48393 (1 unverified)
Lobbying client
rockwell medical technologies
Name
ROCKWELL MEDICAL, INC., Rockwell Medical, Inc. (DE), ROCKWELL MEDICAL TECHNOLOGIES INC
Wikidata
Q17131128
Wikipedia
Rockwell Medical
  • Federal lobbying disclosures (LDA)2 records, 41 data points1 Dec 2015 to 31 Mar 2019
  • SEC Form 13F institutional holdings481 data points30 Jun 2013 to 30 Sep 2026
  • SEC EDGAR filings (8-K items, S-1, Form D, 10-K/10-Q)200 records16 Feb 2016 to 12 Nov 2026
  • SEC XBRL company facts (revenue, capex, R&D, backlog...)1164 data points31 Dec 2008 to 9 Nov 2026
  • SEC Form 4 insider transactions48 records, 136 data points16 Aug 2016 to 5 Oct 2026
  • FINRA short interest (twice monthly)624 data points29 Dec 2017 to 30 Oct 2026
  • FINRA daily short sale volume (off-exchange)4178 data points1 Aug 2018 to 20 Nov 2026
  • Wikipedia pageviews2877 data points1 Jan 2019 to 20 Nov 2026